Oct 25, 2023
The worldwide public relations market is valued at approximately $107 billion U.S. dollars in 2023.
IIROC Trade Halt - T-Bird Pharma Inc.
March 11, 2015 12:54 PM EDT | Source: Emerald Health Therapeutics, Inc.
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2015) - The following issues have been halted by IIROC:
| Company: | T-Bird Pharma Inc. |
| TSX-V Symbol: | TPI |
| Reason: | At the Request of the Company Pending News |
| Halt Time (ET) | 12:46 |
IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
- 30 -
For further information: IIROC Inquiries 1-877-442-4322 (Option 3) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.